ES460686A1 - Un procedimiento para la preparacion de 5-m-tolioxiuracilo. - Google Patents

Un procedimiento para la preparacion de 5-m-tolioxiuracilo.

Info

Publication number
ES460686A1
ES460686A1 ES460686A ES460686A ES460686A1 ES 460686 A1 ES460686 A1 ES 460686A1 ES 460686 A ES460686 A ES 460686A ES 460686 A ES460686 A ES 460686A ES 460686 A1 ES460686 A1 ES 460686A1
Authority
ES
Spain
Prior art keywords
tolyloxyuracil
formula
pharmaceutically acceptable
ulcer agent
resulting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES460686A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES460686A1 publication Critical patent/ES460686A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
ES460686A 1976-07-16 1977-07-13 Un procedimiento para la preparacion de 5-m-tolioxiuracilo. Expired ES460686A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/706,123 US4080454A (en) 1976-07-16 1976-07-16 5-M-Tolyloxyuracil, anti-ulcer agent

Publications (1)

Publication Number Publication Date
ES460686A1 true ES460686A1 (es) 1978-12-01

Family

ID=24836300

Family Applications (1)

Application Number Title Priority Date Filing Date
ES460686A Expired ES460686A1 (es) 1976-07-16 1977-07-13 Un procedimiento para la preparacion de 5-m-tolioxiuracilo.

Country Status (29)

Country Link
US (1) US4080454A (show.php)
JP (1) JPS5337673A (show.php)
AR (1) AR213652A1 (show.php)
AT (1) AT351561B (show.php)
BE (1) BE856710A (show.php)
CA (1) CA1061788A (show.php)
CH (1) CH622512A5 (show.php)
CS (1) CS212264B2 (show.php)
DD (1) DD131556A5 (show.php)
DE (1) DE2731736A1 (show.php)
DK (1) DK139029B (show.php)
EG (1) EG12762A (show.php)
ES (1) ES460686A1 (show.php)
FI (1) FI772183A7 (show.php)
FR (1) FR2358399A1 (show.php)
GB (1) GB1542178A (show.php)
GR (1) GR68686B (show.php)
HU (1) HU177713B (show.php)
IL (1) IL52409A (show.php)
LU (1) LU77764A1 (show.php)
NL (1) NL7707729A (show.php)
NO (1) NO772489L (show.php)
PH (1) PH13190A (show.php)
PL (1) PL103783B1 (show.php)
PT (1) PT66808B (show.php)
SE (1) SE421125B (show.php)
SU (1) SU673169A3 (show.php)
YU (1) YU171677A (show.php)
ZA (1) ZA773927B (show.php)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55158095A (en) * 1979-05-25 1980-12-09 Zenkosha Tokei Kk Controller for washing machine
WO2007024863A2 (en) 2005-08-22 2007-03-01 Melior Discovery, Inc. Methods and formulations for modulating lyn kinase activity and treating related disorders
WO2008103692A2 (en) * 2007-02-20 2008-08-28 Melior Pharmaceuticals I, Inc. Methods of identifying activators of lyn kinase
US20100197710A1 (en) * 2007-07-23 2010-08-05 Melior Pharmaceuticals I, Inc. Methods Of Activating IRS-1 And AKT
US8552184B2 (en) * 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
WO2011150300A1 (en) * 2010-05-28 2011-12-01 Melior Pharmaceuticals I, Inc. Prevention of pancreatic beta cell degeneration
CA3059432A1 (en) 2017-04-10 2018-10-18 Melior Pharmaceuticals I, Inc. Compositions comprising a lyn kinase activator and a trpms agonist
CA3088178A1 (en) 2018-02-21 2019-08-29 Melior Pharmaceuticals I, Inc. Treatment of liver diseases

Also Published As

Publication number Publication date
SE7707471L (sv) 1978-01-17
GB1542178A (en) 1979-03-14
JPS5337673A (en) 1978-04-06
DK139029B (da) 1978-12-04
CH622512A5 (show.php) 1981-04-15
PT66808B (en) 1978-12-21
AU2663877A (en) 1978-05-18
SE421125B (sv) 1981-11-30
PT66808A (en) 1977-08-01
NO772489L (no) 1978-01-17
PL103783B1 (pl) 1979-07-31
AT351561B (de) 1979-08-10
FI772183A7 (show.php) 1978-01-17
LU77764A1 (show.php) 1978-02-02
PH13190A (en) 1980-01-16
ZA773927B (en) 1978-05-30
DK318177A (show.php) 1978-01-17
YU171677A (en) 1982-06-30
EG12762A (en) 1979-12-31
ATA509277A (de) 1979-01-15
HU177713B (en) 1981-12-28
FR2358399B1 (show.php) 1980-10-17
GR68686B (show.php) 1982-02-01
NL7707729A (nl) 1978-01-18
PL199633A1 (pl) 1978-04-10
FR2358399A1 (fr) 1978-02-10
CA1061788A (en) 1979-09-04
BE856710A (fr) 1978-01-11
US4080454A (en) 1978-03-21
CS212264B2 (en) 1982-03-26
JPS5512017B2 (show.php) 1980-03-29
IL52409A0 (en) 1977-08-31
IL52409A (en) 1979-11-30
DD131556A5 (de) 1978-07-05
DK139029C (show.php) 1979-05-07
DE2731736A1 (de) 1978-01-26
AR213652A1 (es) 1979-02-28
SU673169A3 (ru) 1979-07-05

Similar Documents

Publication Publication Date Title
ES8705886A1 (es) Un metodo para preparar un derivadode tiazolidin-diona
ES8507104A1 (es) Un metodo para producir un derivado de amina
IL48637A (en) 2-(tetrazol-5-yl)-9-oxo(hydroxy)-11-desoxy-15wpentanorprosstanoic acid derivatives and pharmaceutical compositions containing them
GB1129393A (en) Tetrazolyl alkanoic acids
ES460686A1 (es) Un procedimiento para la preparacion de 5-m-tolioxiuracilo.
IT7848704A0 (it) Procedimento per la produzione dicloro mediante ossidazione di acido cloridrico
ES8101606A1 (es) Un procedimiento para la preparacion de esteres y eteres fa-cilmente hidrolizables de derivados acilados
ES8502688A1 (es) Procedimiento para preparar derivados de quinolina
ES8100263A1 (es) Procedimiento para preparar un derivado de acido 1-bencil-1,2,5,6-tetrahidropiridina-3-carboxilico
IT7926964A0 (it) Procedimento per la produzione di derivati dell'acido fenossicarbossilico.
EP0009636A3 (en) 3-chloro-6-hydroxy-5-methylbenzoic acid derivative, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds in the treatment and prophylaxis of diseases and for promoting growth of certain animals, and their manufacture
IT7949340A0 (it) Procedimento per la produzione di alcool benzilici per decarbonila zione di esteri di acido formico
ES437012A1 (es) Un procedimiento para la preparacion de derivados de bencil-pirimidina.
GR37361B (el) Μεθοδος δια την παρασκευην παραγωγων του διαρυλοκυκλοπροπανιου.
ES8403889A1 (es) Un metodo para preparar un compuesto de 1,4-dihidropiridina.
IT8025223A0 (it) Procedimento per la produzione di derivati dell'acido penicillanico.
ES8502444A1 (es) Procedimiento para preparar derivados de acido 7-amino-cefalosporanico
IT7921809A0 (it) Metodo per la produzione di derivati dell'acido 6-beta-amidino-penicillanico.
IT7950548A0 (it) Procedimento per la produzione di acido di-n-protilacetico
ES8105311A1 (es) Un procedimiento para la preparacion de acido 3-tienilmalo- nico
ATE10635T1 (de) Alpha-substituierte ureid obenzylpenizillansaeurederivate und verfahren zu ihrer herstellung.
IT7925884A0 (it) Procedimento migliorato per laproduzione di acido ascorbico.
ES458790A1 (es) Un procedimiento para la produccion de acido 6-(d-2(3-hi- droxipiridazin-4-carbonamido)-2-(p-hidroxifenil) acetamido) penicilanico.
FR2166143A1 (en) Alkyl 2,3,3-triiodoallyl ethers - with antimicrobial activity used as disinfectants, poultry feed additives an swine dysen
FR1071798A (fr) Procédé pour la production de dérivés d'acides 1-aminoanthraquinones-2-carboxyliques